The answers to some of medicine's biggest challenges are hiding in the rarest of diseases. A new podcast from Pacific ...

Anne Banner said the rebrand has no set deadline for completion, but officials are incrementally incorporating the title throughout this year and forward.

EpiVax, Inc., a leader in preclinical immunogenicity assessment for biologic therapeutics and vaccines, is pleased to announce the appointment ...

West Bengal bans 137 substandard medicines, conducts quality checks, recalls drugs, and cracks down on fake medicines.

These achievements further reinforce ONWARD's leadership in developing BCI-enabled movement solutions for individuals with ...

Regeneron bids for 23andMe at a discounted price of $256 million. The testing firm was once valued at $3.5 billion.

Here's our list of the leaders in Massachusetts tech, biotech and climate tech who aren't just surviving, but moving their ...

The presentation titled “ Time to Diagnosis of Lung Cancer from Identification of a Pulmonary Nodule in the United States ” was presented yesterday by Kimberly Le, Biodesix Director of Health ...

Groundbreaking procedures extend ONWARD's leadership in the rapidly emerging brain-computer interface (BCI) fieldARC-BCI Therapy is designed to restore thought-driven movement after spinal cord injury ...

Use precise geolocation data. Actively scan device characteristics for identification. Store and/or access information on a ...

A FLURRY OF class action lawsuits against a South Bay digital tech management company landed in federal court this week after a data breach allegedly ...